Vaxart Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 505.06. In total, the insiders bought 10 253 210 and sold 241 812 VXRT shares in the last 100 trades.

Insider Power

(Last 100 transactions)
505.06
Buy 10 253 210 Shares
Sell 241 812 Shares

Historical Insider Trades

Date Type Action Person Amount
Mar 17, 2033 Stock Option (right to buy) Buy Lee Phillip E 410 000
Jun 18, 2024 Common Stock Buy Watson W. Mark 20 000
Jun 12, 2024 Common Stock Sell Lee Phillip E 2 007
Jun 11, 2024 Stock Option (right to buy) Buy Wheadon David E. 95 400
Jun 11, 2024 Common Stock Buy Wheadon David E. 16 000
Jun 11, 2024 Common Stock Buy Finney Michael J. 16 000
Jun 11, 2024 Stock Option (right to buy) Buy Finney Michael J. 95 400
Jun 11, 2024 Stock Option (right to buy) Buy Heron Elaine J 95 400
Jun 11, 2024 Common Stock Buy Heron Elaine J 16 000
Jun 11, 2024 Stock Option (right to buy) Buy Watson W. Mark 95 400
Jun 11, 2024 Common Stock Buy Watson W. Mark 16 000
Jun 11, 2024 Stock Option (right to buy) Buy Yedid Robert A. 95 400
Jun 11, 2024 Common Stock Buy Yedid Robert A. 16 000
Mar 28, 2024 Common Stock Sell Tucker Sean 3 902
Mar 28, 2024 Common Stock Sell Cummings James F. 3 292
Mar 18, 2024 Common Stock Buy Tucker Sean 90 000
Mar 18, 2024 Stock Option (right to buy) Buy Tucker Sean 410 000
Mar 18, 2024 Stock Option (right to buy) Buy Lee Phillip E 410 000
Mar 18, 2024 Common Stock Buy Lee Phillip E 90 000
Mar 18, 2024 Stock Option (right to buy) Buy Cummings James F. 410 000
Mar 18, 2024 Common Stock Buy Cummings James F. 90 000
Mar 18, 2024 Stock Option (right to buy) Buy Berg Edward B 410 000
Mar 18, 2024 Common Stock Buy Berg Edward B 90 000
Mar 18, 2024 Stock Option (right to buy) Buy Lo Steven 1 000 000
Mar 18, 2024 Common Stock Buy Lo Steven 250 000
Click to get the best stock tips daily for free!

About Vaxart

Vaxart Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1 and GII.4 norovirus strains; seasonal influenza vaccine, which is in Phase II clinical trial for the t... VXRT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT